主要文件

查看所有文档

Y0000821

吗多明

Name: 吗多明
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

N-(Ethoxycarbonyl)-3-(4-morpholino)sydnone imine, SIN-10

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₉H₁₄N₄O₄

化学文摘社编号:

25717-80-0

分子量:

242.23

NACRES:

NA.24

PubChem Substance ID:

329831170

UNSPSC Code:

41116107

MDL number:

MFCD00869301

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

pharmaceutical primary standard

API family

molsidomine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

CCOC(=O)N=C1O[N-][N+](=C1)N2CCOCC2

InChI

1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3/b10-8-

InChI key

XLFWDASMENKTKL-NTMALXAHSA-N

说明

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Molsidomine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Still not finding the right product?

Explore all of our products under 吗多明

pictograms

GHS07

signalword

Warning

hcodes

H302

pcodes

P301 + P312 + P330

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Molsidomine: alternative approaches to treat myocardial ischemia.

R E Nitz et al.

Pharmacotherapy, 7(1), 28-37 (1987-01-01)

The long-acting antianginal drug molsidomine has been shown experimentally to reduce myocardial infarct size when administered prior to or after cardiac insult. This is due to several drug actions. Dilation of postcapillary capacitance vessels diminishes venous return, preload, heart dimensions

[Molsidomine (Corvaton)].

O M Eliseev

Terapevticheskii arkhiv, 66(9), 82-88 (1994-01-01)

[Pharmacology of molsidomine and its active metabolites].

E Böhme

Medizinische Klinik (Munich, Germany : 1983), 85 Suppl 1, 7-10 (1990-02-01)

查看所有相关文献

全球贸易项目编号

货号	GTIN
Y0000821	04061833796566